Aristocort A

ANDA 88820, held by Astellas. Triamcinolone Acetonide.

As of Nov 15, 2026, ANDA 88820 (Aristocort A), held by Astellas, was first approved by FDA on Oct 16, 1984, with 8 approved supplements and 0 published complete response letters.

First approved: Oct 16, 1984
Supplements approved: 8
Complete response letters: 0

Approvals and New Uses

The original application and every efficacy supplement, newest first; all 9 submissions below

Date	Submission	Status	Documents
Oct 16, 1984	Original application	Approved	None posted

Products

1 strengths and forms

Product	Active ingredient	Marketing
Aristocort A0.5% · cream;topical	Triamcinolone Acetonide	Discontinued

All 9 submissions, including labeling and manufacturing supplements


May 6, 1998	Supplement 7Manufacturing	Approved	None posted
May 6, 1998	Supplement 8Manufacturing	Approved	None posted
May 6, 1998	Supplement 9Manufacturing	Approved	None posted
May 6, 1998	Supplement 10Manufacturing	Approved	None posted
May 20, 1991	Supplement 6Manufacturing	Approved	None posted
Dec 8, 1989	Supplement 3Manufacturing	Approved	None posted
Dec 8, 1989	Supplement 4Manufacturing	Approved	None posted
Dec 8, 1989	Supplement 5Labeling	Approved	None posted
Oct 16, 1984	Original application	Approved	None posted

Identifiers

Application: ANDA 88820
Drugs@FDA: Overview at FDA
Company: Astellas Pharma

Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters